TransMedics (TMDX) Net Cash Flow (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -137.84% |
| Dec 31, 2025 | -66.31% |
| Sep 30, 2025 | -26.82% |
| Jun 30, 2025 | 433.61% |
| Mar 31, 2025 | -470.91% |
| Dec 31, 2024 | 121.92% |
| Sep 30, 2024 | -362.33% |
| Jun 30, 2024 | 128.36% |
| Mar 31, 2024 | -36.31% |
| Dec 31, 2023 | 79.00% |
| Sep 30, 2023 | -140.11% |
| Jun 30, 2023 | 6,970.87% |
| Mar 31, 2023 | -50.78% |
| Dec 31, 2022 | -102.14% |
| Sep 30, 2022 | 1,227.60% |
| Jun 30, 2022 | 275.74% |
| Mar 31, 2022 | -320.92% |
| Dec 31, 2021 | 230.40% |
| Sep 30, 2021 | -71.10% |
| Jun 30, 2021 | -160.16% |
| Mar 31, 2021 | -9.14% |
| Dec 31, 2020 | 109.24% |
| Sep 30, 2020 | -214.40% |
| Jun 30, 2020 | 460.22% |
| Mar 31, 2020 | 3,227.33% |
| Dec 28, 2019 | 99.44% |
| Sep 28, 2019 | -176.89% |
| Jun 29, 2019 | 537.38% |
| Mar 30, 2019 | 6.66% |
| Dec 29, 2018 | -52.53% |
| Sep 29, 2018 | -122.59% |
| Jun 30, 2018 | 1,200.27% |